메뉴 건너뛰기




Volumn 30, Issue 12, 2014, Pages 562-570

Neglected tools for neglected diseases: Mathematical models in economic evaluations

Author keywords

Analysis theoretical models; Control programmes; Cost benefit; Cost effectiveness; Economic evaluation studies; Epidemiology; Mathematical modelling; Neglected tropical diseases (NTDs)

Indexed keywords

CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DYNAMIC TRANSMISSION MODEL; ECONOMIC EVALUATION; EMPIRICISM; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH IMPACT ASSESSMENT; HOST PARASITE INTERACTION; HUMAN; INFECTION CONTROL; INTERVENTION STUDY; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; NEGLECTED DISEASE; NEGLECTED TROPICAL DISEASE; NONLINEAR SYSTEM; PARASITE TRANSMISSION; PATHOGEN CLEARANCE; POPULATION ABUNDANCE; RESOURCE ALLOCATION; REVIEW; STATIC INFECTION MODEL; SYSTEMATIC REVIEW; TROPICAL DISEASE; VACCINATION; VALIDATION STUDY; COST BENEFIT ANALYSIS; ECONOMICS; NEGLECTED DISEASES; RESEARCH; THEORETICAL MODEL; TRENDS; WORLD HEALTH ORGANIZATION;

EID: 84922793924     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2014.10.001     Document Type: Review
Times cited : (29)

References (98)
  • 1
    • 34548422845 scopus 로고    scopus 로고
    • Control of neglected tropical diseases
    • Hotez P.J., et al. Control of neglected tropical diseases. N. Engl. J. Med. 2007, 357:1018-1027.
    • (2007) N. Engl. J. Med. , vol.357 , pp. 1018-1027
    • Hotez, P.J.1
  • 2
    • 32644489818 scopus 로고    scopus 로고
    • The Lancet's chronic diseases series
    • author reply 564-565
    • Hotez P., et al. The Lancet's chronic diseases series. Lancet 2006, 367:563-564. author reply 564-565.
    • (2006) Lancet , vol.367 , pp. 563-564
    • Hotez, P.1
  • 3
    • 84905507693 scopus 로고    scopus 로고
    • The Global Burden of Disease Study 2010: implications for the neglected tropical diseases
    • Hotez P., et al. The Global Burden of Disease Study 2010: implications for the neglected tropical diseases. PLoS Negl. Trop. Dis. 2014, 8:e2865.
    • (2014) PLoS Negl. Trop. Dis. , vol.8 , pp. e2865
    • Hotez, P.1
  • 4
    • 33744486308 scopus 로고    scopus 로고
    • Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria
    • Hotez P.J., et al. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 2006, 3:e102.
    • (2006) PLoS Med. , vol.3 , pp. e102
    • Hotez, P.J.1
  • 5
    • 84922772368 scopus 로고    scopus 로고
    • Ending the neglect and reaching 2020 goals
    • London Declaration on Neglected Tropical Diseases (2103)
    • London Declaration on Neglected Tropical Diseases (2103) Ending the neglect and reaching 2020 goals.(http://unitingtocombatntds.org/downloads/press/ntd_event_london_declaration_on_ntds.pdf).
  • 7
    • 33645966537 scopus 로고    scopus 로고
    • Advancement of global health: key messages from the Disease Control Priorities Project
    • Laxminarayan R., et al. Advancement of global health: key messages from the Disease Control Priorities Project. Lancet 2006, 367:1193-1208.
    • (2006) Lancet , vol.367 , pp. 1193-1208
    • Laxminarayan, R.1
  • 9
    • 0037280384 scopus 로고    scopus 로고
    • Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices - modeling studies
    • Weinstein M.C., et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices - modeling studies. Value Health 2003, 6:9-17.
    • (2003) Value Health , vol.6 , pp. 9-17
    • Weinstein, M.C.1
  • 10
    • 77951727815 scopus 로고    scopus 로고
    • Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic
    • Lugner A.K., et al. Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic. Health Econ. 2010, 19:518-531.
    • (2010) Health Econ. , vol.19 , pp. 518-531
    • Lugner, A.K.1
  • 11
    • 0027772390 scopus 로고
    • Markov models in medical decision making: a practical guide
    • Sonnenberg F.A., Beck J.R. Markov models in medical decision making: a practical guide. Med. Decis. Making 1993, 13:322-338.
    • (1993) Med. Decis. Making , vol.13 , pp. 322-338
    • Sonnenberg, F.A.1    Beck, J.R.2
  • 12
    • 0031886073 scopus 로고    scopus 로고
    • An introduction to Markov modelling for economic evaluation
    • Briggs A., Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998, 13:397-409.
    • (1998) Pharmacoeconomics , vol.13 , pp. 397-409
    • Briggs, A.1    Sculpher, M.2
  • 13
    • 33645805255 scopus 로고    scopus 로고
    • Optimal assignment of treatments to health states using a Markov decision model: an introduction to basic concepts
    • Bala M.V., Mauskopf J.A. Optimal assignment of treatments to health states using a Markov decision model: an introduction to basic concepts. Pharmacoeconomics 2006, 24:345-354.
    • (2006) Pharmacoeconomics , vol.24 , pp. 345-354
    • Bala, M.V.1    Mauskopf, J.A.2
  • 14
    • 39449117720 scopus 로고    scopus 로고
    • Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches
    • Kim S.Y., Goldie S.J. Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches. Pharmacoeconomics 2008, 26:191-215.
    • (2008) Pharmacoeconomics , vol.26 , pp. 191-215
    • Kim, S.Y.1    Goldie, S.J.2
  • 15
    • 0033573302 scopus 로고    scopus 로고
    • Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective
    • Edmunds W.J., et al. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat. Med. 1999, 18:3263-3282.
    • (1999) Stat. Med. , vol.18 , pp. 3263-3282
    • Edmunds, W.J.1
  • 16
    • 2142651557 scopus 로고    scopus 로고
    • Modeling infection transmission
    • Koopman J. Modeling infection transmission. Annu. Rev. Public Health 2004, 25:303-326.
    • (2004) Annu. Rev. Public Health , vol.25 , pp. 303-326
    • Koopman, J.1
  • 18
    • 33845603069 scopus 로고    scopus 로고
    • A taxonomy of model structures for economic evaluation of health technologies
    • Brennan A., et al. A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 2006, 15:1295-1310.
    • (2006) Health Econ. , vol.15 , pp. 1295-1310
    • Brennan, A.1
  • 19
    • 84859005659 scopus 로고    scopus 로고
    • A research agenda for helminth diseases of humans: modelling for control and elimination
    • Basáñez M.G., et al. A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl. Trop. Dis. 2012, 6:e1548.
    • (2012) PLoS Negl. Trop. Dis. , vol.6 , pp. e1548
    • Basáñez, M.G.1
  • 20
    • 42949105579 scopus 로고    scopus 로고
    • Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis
    • Basáñez M.G., et al. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect. Dis. 2008, 8:310-322.
    • (2008) Lancet Infect. Dis. , vol.8 , pp. 310-322
    • Basáñez, M.G.1
  • 21
    • 0035810631 scopus 로고    scopus 로고
    • Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment
    • Hoerauf A., et al. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 2001, 357:1415-1416.
    • (2001) Lancet , vol.357 , pp. 1415-1416
    • Hoerauf, A.1
  • 22
    • 0037388065 scopus 로고    scopus 로고
    • Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms
    • Hoerauf A., et al. Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect. 2003, 5:261-273.
    • (2003) Microbes Infect. , vol.5 , pp. 261-273
    • Hoerauf, A.1
  • 23
    • 44549084895 scopus 로고    scopus 로고
    • Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study
    • Hoerauf A., et al. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med. Microbiol. Immunol. 2008, 197:295-311.
    • (2008) Med. Microbiol. Immunol. , vol.197 , pp. 295-311
    • Hoerauf, A.1
  • 24
    • 84882809188 scopus 로고    scopus 로고
    • Ch 22 Vaccines linked to chemotherapy: a new approach to control helminth infections
    • Wiley-VCH Verlag, C.R. Caffrey (Ed.)
    • Lustigman S., et al. Ch 22 Vaccines linked to chemotherapy: a new approach to control helminth infections. Parasitic Helminths: Targets, Screens, Drugs and Vaccines 2012, Wiley-VCH Verlag. C.R. Caffrey (Ed.).
    • (2012) Parasitic Helminths: Targets, Screens, Drugs and Vaccines
    • Lustigman, S.1
  • 26
    • 0000759048 scopus 로고    scopus 로고
    • Disease eradication: private versus public vaccination
    • Geoffard P.Y., Philipson T. Disease eradication: private versus public vaccination. Am. Econ. Rev. 1997, 87:222-230.
    • (1997) Am. Econ. Rev. , vol.87 , pp. 222-230
    • Geoffard, P.Y.1    Philipson, T.2
  • 27
    • 33749669949 scopus 로고    scopus 로고
    • Density dependence and the control of helminth parasites
    • Churcher T.S., et al. Density dependence and the control of helminth parasites. J. Anim. Ecol. 2006, 75:1313-1320.
    • (2006) J. Anim. Ecol. , vol.75 , pp. 1313-1320
    • Churcher, T.S.1
  • 28
    • 61849096677 scopus 로고    scopus 로고
    • Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus
    • Basáñez M.G., et al. Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv. Parasitol. 2009, 68:263-313.
    • (2009) Adv. Parasitol. , vol.68 , pp. 263-313
    • Basáñez, M.G.1
  • 29
    • 0023932760 scopus 로고
    • Density-dependence in parasite transmission dynamics
    • Dietz K. Density-dependence in parasite transmission dynamics. Parasitol. Today 1988, 4:91-97.
    • (1988) Parasitol. Today , vol.4 , pp. 91-97
    • Dietz, K.1
  • 30
    • 22444448312 scopus 로고    scopus 로고
    • Density dependence and overdispersion in the transmission of helminth parasites
    • Churcher T.S., et al. Density dependence and overdispersion in the transmission of helminth parasites. Parasitology 2005, 131:121-132.
    • (2005) Parasitology , vol.131 , pp. 121-132
    • Churcher, T.S.1
  • 31
    • 15744364874 scopus 로고    scopus 로고
    • Mass antibiotics for trachoma and the Allee effect
    • Chidambaram J.D., et al. Mass antibiotics for trachoma and the Allee effect. Lancet Infect. Dis. 2005, 5:194-196.
    • (2005) Lancet Infect. Dis. , vol.5 , pp. 194-196
    • Chidambaram, J.D.1
  • 32
    • 79955757313 scopus 로고    scopus 로고
    • The epidemiological dynamics of infectious trachoma may facilitate elimination
    • Lietman T.M., et al. The epidemiological dynamics of infectious trachoma may facilitate elimination. Epidemics 2011, 3:119-124.
    • (2011) Epidemics , vol.3 , pp. 119-124
    • Lietman, T.M.1
  • 33
    • 0034024193 scopus 로고    scopus 로고
    • Economic evaluation of parasitic diseases: a critique of the internal and external validity of published studies
    • Walker D., Fox-Rushby J. Economic evaluation of parasitic diseases: a critique of the internal and external validity of published studies. Trop. Med. Int. Health 2000, 5:237-249.
    • (2000) Trop. Med. Int. Health , vol.5 , pp. 237-249
    • Walker, D.1    Fox-Rushby, J.2
  • 34
    • 84874772719 scopus 로고    scopus 로고
    • How effective is school-based deworming for the community-wide control of soil-transmitted helminths?
    • Anderson R.M., et al. How effective is school-based deworming for the community-wide control of soil-transmitted helminths?. PLoS Negl. Trop. Dis. 2013, 7:e2027.
    • (2013) PLoS Negl. Trop. Dis. , vol.7 , pp. e2027
    • Anderson, R.M.1
  • 35
    • 84904007322 scopus 로고    scopus 로고
    • Can chemotherapy alone eliminate the transmission of soil transmitted helminths?
    • Truscott J., et al. Can chemotherapy alone eliminate the transmission of soil transmitted helminths?. Parasit. Vectors 2014, 7:266.
    • (2014) Parasit. Vectors , vol.7 , pp. 266
    • Truscott, J.1
  • 36
    • 84900312342 scopus 로고    scopus 로고
    • The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths
    • Anderson R.M., et al. The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2014, 369:20130435.
    • (2014) Philos. Trans. R. Soc. Lond. B: Biol. Sci. , vol.369 , pp. 20130435
    • Anderson, R.M.1
  • 37
    • 72849146247 scopus 로고    scopus 로고
    • Neglected tropical diseases: infection, modeling, and control
    • Kealey A., Smith R. Neglected tropical diseases: infection, modeling, and control. J. Health Care Poor Underserved 2010, 21:53-69.
    • (2010) J. Health Care Poor Underserved , vol.21 , pp. 53-69
    • Kealey, A.1    Smith, R.2
  • 38
    • 77953772701 scopus 로고    scopus 로고
    • Optimal survey designs for targeting chemotherapy against soil-transmitted helminths: effect of spatial heterogeneity and cost-efficiency of sampling
    • Sturrock H.J., et al. Optimal survey designs for targeting chemotherapy against soil-transmitted helminths: effect of spatial heterogeneity and cost-efficiency of sampling. Am. J. Trop. Med. Hyg. 2010, 82:1079-1087.
    • (2010) Am. J. Trop. Med. Hyg. , vol.82 , pp. 1079-1087
    • Sturrock, H.J.1
  • 39
    • 84916935300 scopus 로고    scopus 로고
    • Health metrics for helminth infections
    • Published online December 12, 2013
    • King C.H. Health metrics for helminth infections. Acta Trop. 2013, Published online December 12, 2013. 10.1016/j.actatropica.2013.12.001.
    • (2013) Acta Trop.
    • King, C.H.1
  • 40
    • 84875614866 scopus 로고    scopus 로고
    • Global economic burden of Chagas disease: a computational simulation model
    • Lee B.Y., et al. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect. Dis. 2013, 13:342-348.
    • (2013) Lancet Infect. Dis. , vol.13 , pp. 342-348
    • Lee, B.Y.1
  • 41
    • 74049146746 scopus 로고    scopus 로고
    • Socioeconomic aspects of neglected tropical diseases
    • Conteh L., et al. Socioeconomic aspects of neglected tropical diseases. Lancet 2010, 375:239-247.
    • (2010) Lancet , vol.375 , pp. 239-247
    • Conteh, L.1
  • 42
    • 43349095895 scopus 로고    scopus 로고
    • National mass drug administration costs for lymphatic filariasis elimination
    • Goldman A.S., et al. National mass drug administration costs for lymphatic filariasis elimination. PLoS Negl. Trop. Dis. 2007, 1:e67.
    • (2007) PLoS Negl. Trop. Dis. , vol.1 , pp. e67
    • Goldman, A.S.1
  • 43
    • 84898982764 scopus 로고    scopus 로고
    • Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review
    • Keating J., et al. Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review. Acta Trop. 2014, 135:86-95.
    • (2014) Acta Trop. , vol.135 , pp. 86-95
    • Keating, J.1
  • 44
    • 14644408763 scopus 로고    scopus 로고
    • Costs of scaling up health interventions: a systematic review
    • Johns B., Torres T.T. Costs of scaling up health interventions: a systematic review. Health Policy Plan. 2005, 20:1-13.
    • (2005) Health Policy Plan. , vol.20 , pp. 1-13
    • Johns, B.1    Torres, T.T.2
  • 45
    • 84888217953 scopus 로고    scopus 로고
    • Guide for preparing an eradication investment case
    • Walker, D.G. and Lupp, J. (2011) Guide for preparing an eradication investment case.(http://eic-guidelines.org/).
    • (2011)
    • Walker, D.G.1    Lupp, J.2
  • 46
    • 84888238571 scopus 로고    scopus 로고
    • Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges
    • Tediosi F., et al. Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges. PLoS Negl. Trop. Dis. 2013, 7:e2446.
    • (2013) PLoS Negl. Trop. Dis. , vol.7 , pp. e2446
    • Tediosi, F.1
  • 47
    • 79960160515 scopus 로고    scopus 로고
    • Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites
    • Koukounari A., et al. Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites. BMC Infect. Dis. 2011, 11:191.
    • (2011) BMC Infect. Dis. , vol.11 , pp. 191
    • Koukounari, A.1
  • 48
    • 0028085649 scopus 로고
    • Quantifying disability: data, methods and results
    • Murray C.J.L., Lopez A.D. Quantifying disability: data, methods and results. Bull. World Health Organ. 1994, 72:481-494.
    • (1994) Bull. World Health Organ. , vol.72 , pp. 481-494
    • Murray, C.J.L.1    Lopez, A.D.2
  • 49
    • 0025297188 scopus 로고
    • Selection of MDT strategies through epidemiometric modeling
    • Lechat M.F., et al. Selection of MDT strategies through epidemiometric modeling. Int. J. Lepr. Other Mycobact. Dis. 1990, 58:296-301.
    • (1990) Int. J. Lepr. Other Mycobact. Dis. , vol.58 , pp. 296-301
    • Lechat, M.F.1
  • 50
    • 0017808819 scopus 로고
    • Application of an economic model to the study of leprosy control costs
    • Lechat M.F., et al. Application of an economic model to the study of leprosy control costs. Int. J. Lepr. Other Mycobact. Dis. 1978, 46:14-24.
    • (1978) Int. J. Lepr. Other Mycobact. Dis. , vol.46 , pp. 14-24
    • Lechat, M.F.1
  • 51
    • 77957007655 scopus 로고    scopus 로고
    • The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007)
    • Chu B.K., et al. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007). PLoS Negl. Trop. Dis. 2010, 4:e708.
    • (2010) PLoS Negl. Trop. Dis. , vol.4 , pp. e708
    • Chu, B.K.1
  • 52
    • 51849124236 scopus 로고    scopus 로고
    • Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes
    • Michael E., et al. Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes. PLoS ONE 2008, 3:e2936.
    • (2008) PLoS ONE , vol.3 , pp. e2936
    • Michael, E.1
  • 53
    • 84873503636 scopus 로고    scopus 로고
    • Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis
    • Stolk W.A., et al. Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis. PLoS Negl. Trop. Dis. 2013, 7:e1984.
    • (2013) PLoS Negl. Trop. Dis. , vol.7 , pp. e1984
    • Stolk, W.A.1
  • 54
    • 84858068808 scopus 로고    scopus 로고
    • Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study
    • Baltussen R., Smith A. Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2012, 344:e615.
    • (2012) BMJ , vol.344 , pp. e615
    • Baltussen, R.1    Smith, A.2
  • 55
    • 23444445512 scopus 로고    scopus 로고
    • Cost-effectiveness of trachoma control in seven world regions
    • Baltussen R., et al. Cost-effectiveness of trachoma control in seven world regions. Ophthalmic Epidemiol. 2005, 12:91-101.
    • (2005) Ophthalmic Epidemiol. , vol.12 , pp. 91-101
    • Baltussen, R.1
  • 56
    • 1642493617 scopus 로고    scopus 로고
    • Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis
    • Frick K.D., et al. Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis. Vaccine 2004, 22:689-696.
    • (2004) Vaccine , vol.22 , pp. 689-696
    • Frick, K.D.1
  • 57
    • 78649762910 scopus 로고    scopus 로고
    • Targeting antibiotics to households for trachoma control
    • Blake I.M., et al. Targeting antibiotics to households for trachoma control. PLoS Negl. Trop. Dis. 2010, 4:e862.
    • (2010) PLoS Negl. Trop. Dis. , vol.4 , pp. e862
    • Blake, I.M.1
  • 58
    • 42249098262 scopus 로고    scopus 로고
    • Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda
    • Fèvre E.M., et al. Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda. BMC Public Health 2008, 8:96.
    • (2008) BMC Public Health , vol.8 , pp. 96
    • Fèvre, E.M.1
  • 59
    • 0032233597 scopus 로고    scopus 로고
    • Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee
    • World Health Organization Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. World Health Organ. Tech. Rep. Ser. 1998, 881(I-VI):1-114.
    • (1998) World Health Organ. Tech. Rep. Ser. , vol.881 , Issue.1-6 , pp. 1-114
  • 60
    • 17644391059 scopus 로고    scopus 로고
    • The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense
    • Lutumba P., et al. The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense. Trop. Med. Int. Health 2005, 10:347-356.
    • (2005) Trop. Med. Int. Health , vol.10 , pp. 347-356
    • Lutumba, P.1
  • 61
    • 0029330809 scopus 로고
    • Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda
    • Politi C., et al. Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda. Health Econ. 1995, 4:273-287.
    • (1995) Health Econ. , vol.4 , pp. 273-287
    • Politi, C.1
  • 62
    • 0024408360 scopus 로고
    • Comparative analysis of the costs and benefits of alternative disease control strategies: vector control versus human case finding and treatment
    • Shaw A.P. Comparative analysis of the costs and benefits of alternative disease control strategies: vector control versus human case finding and treatment. Ann. Soc. Belg. Med. Trop. 1989, 69(Suppl. 1):237-253.
    • (1989) Ann. Soc. Belg. Med. Trop. , vol.69 , pp. 237-253
    • Shaw, A.P.1
  • 63
    • 0022490325 scopus 로고
    • Cost and effectiveness of different approaches to schistosomiasis control in Africa
    • Korte R., et al. Cost and effectiveness of different approaches to schistosomiasis control in Africa. Trop. Med. Parasitol. 1986, 37:149-152.
    • (1986) Trop. Med. Parasitol. , vol.37 , pp. 149-152
    • Korte, R.1
  • 64
    • 3442887277 scopus 로고    scopus 로고
    • A cost-benefit analysis of preventive schistosomiasis interventions in Kenya
    • Kirigia J.M., et al. A cost-benefit analysis of preventive schistosomiasis interventions in Kenya. Afr. J. Health Sci. 2000, 7(3-4):5-11.
    • (2000) Afr. J. Health Sci. , vol.7 , Issue.3-4 , pp. 5-11
    • Kirigia, J.M.1
  • 65
    • 0029000468 scopus 로고
    • Desirable characteristics of a schistosomiasis vaccine: some implications of a cost-effectiveness analysis
    • Guyatt H.L., Evans D. Desirable characteristics of a schistosomiasis vaccine: some implications of a cost-effectiveness analysis. Acta Trop. 1995, 59:197-209.
    • (1995) Acta Trop. , vol.59 , pp. 197-209
    • Guyatt, H.L.1    Evans, D.2
  • 66
    • 0023191326 scopus 로고
    • The economics of schistosomiasis chemotherapy
    • Prescott N.M. The economics of schistosomiasis chemotherapy. Parasitol. Today 1987, 3:21-24.
    • (1987) Parasitol. Today , vol.3 , pp. 21-24
    • Prescott, N.M.1
  • 67
    • 0030665844 scopus 로고    scopus 로고
    • Human behaviour, cost-effectiveness analysis and research and development priorities: the case of a schistosomiasis vaccine
    • Evans D.B., Guyatt H.L. Human behaviour, cost-effectiveness analysis and research and development priorities: the case of a schistosomiasis vaccine. Trop. Med. Int. Health 1997, 2:A47-A54.
    • (1997) Trop. Med. Int. Health , vol.2 , pp. A47-A54
    • Evans, D.B.1    Guyatt, H.L.2
  • 68
    • 80053435561 scopus 로고    scopus 로고
    • Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review
    • King C.H., et al. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl. Trop. Dis. 2011, 5:1321.
    • (2011) PLoS Negl. Trop. Dis. , vol.5 , pp. 1321
    • King, C.H.1
  • 69
    • 84877337297 scopus 로고    scopus 로고
    • Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa
    • Ndeffo Mbah M.L., et al. Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:7952-7957.
    • (2013) Proc. Natl. Acad. Sci. U.S.A. , vol.110 , pp. 7952-7957
    • Ndeffo Mbah, M.L.1
  • 70
    • 0017735775 scopus 로고
    • Development and verification of a schistosomiasis transmission model
    • Rosenfield P.L., et al. Development and verification of a schistosomiasis transmission model. Am. J. Trop. Med. Hyg. 1977, 26:505-516.
    • (1977) Am. J. Trop. Med. Hyg. , vol.26 , pp. 505-516
    • Rosenfield, P.L.1
  • 71
    • 0031798813 scopus 로고    scopus 로고
    • An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school-targeted treatment for Schistosoma mansoni using a population dynamic model
    • Guyatt H.L., Chan M.S. An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school-targeted treatment for Schistosoma mansoni using a population dynamic model. Trop. Med. Int. Health 1998, 3:425-435.
    • (1998) Trop. Med. Int. Health , vol.3 , pp. 425-435
    • Guyatt, H.L.1    Chan, M.S.2
  • 72
    • 0033811812 scopus 로고    scopus 로고
    • A population dynamic approach to evaluating the impact of school attendance on the unit cost and effectiveness of school-based schistosomiasis chemotherapy programmes
    • Carabin H., et al. A population dynamic approach to evaluating the impact of school attendance on the unit cost and effectiveness of school-based schistosomiasis chemotherapy programmes. Parasitology 2000, 121:171-183.
    • (2000) Parasitology , vol.121 , pp. 171-183
    • Carabin, H.1
  • 73
    • 84883427169 scopus 로고    scopus 로고
    • Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa - the case of Zimbabwean women
    • Ndeffo Mbah M.L., et al. Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa - the case of Zimbabwean women. PLoS Negl. Trop. Dis. 2013, 7:e2346.
    • (2013) PLoS Negl. Trop. Dis. , vol.7 , pp. e2346
    • Ndeffo Mbah, M.L.1
  • 74
    • 84870761341 scopus 로고    scopus 로고
    • Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection
    • Wang X.X., et al. Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection. PLoS Negl. Trop. Dis. 2012, 6:e1903.
    • (2012) PLoS Negl. Trop. Dis. , vol.6 , pp. e1903
    • Wang, X.X.1
  • 75
    • 0032238637 scopus 로고    scopus 로고
    • Different approaches to modelling the cost-effectiveness of schistosomiasis control
    • Guyatt H.L. Different approaches to modelling the cost-effectiveness of schistosomiasis control. Mem. Inst. Oswaldo Cruz 1998, 93(Suppl. 1):75-84.
    • (1998) Mem. Inst. Oswaldo Cruz , vol.93 , pp. 75-84
    • Guyatt, H.L.1
  • 76
    • 84964313551 scopus 로고    scopus 로고
    • Reaching the London Declaration on Neglected Tropical Diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa
    • Turner H.C., et al. Reaching the London Declaration on Neglected Tropical Diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin. Infect. Dis. 2014, 59:923-932.
    • (2014) Clin. Infect. Dis. , vol.59 , pp. 923-932
    • Turner, H.C.1
  • 77
    • 84873519766 scopus 로고    scopus 로고
    • African Programme for Onchocerciasis Control 1995-2015: model-estimated health impact and cost
    • Coffeng L.E., et al. African Programme for Onchocerciasis Control 1995-2015: model-estimated health impact and cost. PLoS Negl. Trop. Dis. 2013, 7:e2032.
    • (2013) PLoS Negl. Trop. Dis. , vol.7 , pp. e2032
    • Coffeng, L.E.1
  • 78
    • 78751572703 scopus 로고    scopus 로고
    • The potential economic value of a hookworm vaccine
    • Lee B.Y., et al. The potential economic value of a hookworm vaccine. Vaccine 2011, 29:1201-1210.
    • (2011) Vaccine , vol.29 , pp. 1201-1210
    • Lee, B.Y.1
  • 79
    • 0028902415 scopus 로고
    • Control of Ascaris infection by chemotherapy: which is the most cost-effective option?
    • Guyatt H.L., et al. Control of Ascaris infection by chemotherapy: which is the most cost-effective option?. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:16-20.
    • (1995) Trans. R. Soc. Trop. Med. Hyg. , vol.89 , pp. 16-20
    • Guyatt, H.L.1
  • 80
    • 0027370440 scopus 로고
    • A population dynamic approach to the cost-effectiveness analysis of mass anthelmintic treatment: effects of treatment frequency on Ascaris infection
    • Guyatt H.L., et al. A population dynamic approach to the cost-effectiveness analysis of mass anthelmintic treatment: effects of treatment frequency on Ascaris infection. Trans. R. Soc. Trop. Med. Hyg. 1993, 87:570-575.
    • (1993) Trans. R. Soc. Trop. Med. Hyg. , vol.87 , pp. 570-575
    • Guyatt, H.L.1
  • 81
    • 84867029445 scopus 로고    scopus 로고
    • Modeling the economic value of a Chagas' disease therapeutic vaccine
    • Lee B.Y., et al. Modeling the economic value of a Chagas' disease therapeutic vaccine. Hum. Vaccin. Immunother. 2012, 8:1293-1301.
    • (2012) Hum. Vaccin. Immunother. , vol.8 , pp. 1293-1301
    • Lee, B.Y.1
  • 82
    • 79955466712 scopus 로고    scopus 로고
    • Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area
    • Sicuri E., et al. Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area. Acta Trop. 2011, 118:110-117.
    • (2011) Acta Trop. , vol.118 , pp. 110-117
    • Sicuri, E.1
  • 83
    • 78650707764 scopus 로고    scopus 로고
    • The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America
    • Lee B.Y., et al. The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America. PLoS Negl. Trop. Dis. 2010, 4:e916.
    • (2010) PLoS Negl. Trop. Dis. , vol.4 , pp. e916
    • Lee, B.Y.1
  • 84
    • 78349253751 scopus 로고    scopus 로고
    • The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model
    • Custer B., et al. The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model. Transfusion 2010, 50:2461-2473.
    • (2010) Transfusion , vol.50 , pp. 2461-2473
    • Custer, B.1
  • 85
    • 78649484203 scopus 로고    scopus 로고
    • Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi
    • Agapova M., et al. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion 2010, 50:2220-2232.
    • (2010) Transfusion , vol.50 , pp. 2220-2232
    • Agapova, M.1
  • 86
    • 65549109816 scopus 로고    scopus 로고
    • Cost-effectiveness of Chagas disease vector control strategies in Northwestern Argentina
    • Vazquez-Prokopec G.M., et al. Cost-effectiveness of Chagas disease vector control strategies in Northwestern Argentina. PLoS Negl. Trop. Dis. 2009, 3:e363.
    • (2009) PLoS Negl. Trop. Dis. , vol.3 , pp. e363
    • Vazquez-Prokopec, G.M.1
  • 87
    • 47049112740 scopus 로고    scopus 로고
    • Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks
    • Wilson L.S., et al. Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. Am. J. Trop. Med. Hyg. 2008, 79:53-68.
    • (2008) Am. J. Trop. Med. Hyg. , vol.79 , pp. 53-68
    • Wilson, L.S.1
  • 88
    • 28044453546 scopus 로고    scopus 로고
    • Cost-effectiveness of Chagas disease interventions in Latin America and the Caribbean: Markov models
    • Wilson L.S., et al. Cost-effectiveness of Chagas disease interventions in Latin America and the Caribbean: Markov models. Am. J. Trop. Med. Hyg. 2005, 73:901-910.
    • (2005) Am. J. Trop. Med. Hyg. , vol.73 , pp. 901-910
    • Wilson, L.S.1
  • 89
    • 0026192180 scopus 로고
    • A cost-benefit analysis of Chagas disease control
    • Schofield C.J., Dias J.C. A cost-benefit analysis of Chagas disease control. Mem. Inst. Oswaldo Cruz 1991, 86:285-295.
    • (1991) Mem. Inst. Oswaldo Cruz , vol.86 , pp. 285-295
    • Schofield, C.J.1    Dias, J.C.2
  • 90
    • 79957971642 scopus 로고    scopus 로고
    • Evaluation of spatially targeted strategies to control non-domiciliated Triatoma dimidiata vector of Chagas disease
    • Barbu C., et al. Evaluation of spatially targeted strategies to control non-domiciliated Triatoma dimidiata vector of Chagas disease. PLoS Negl. Trop. Dis. 2011, 5:e1045.
    • (2011) PLoS Negl. Trop. Dis. , vol.5 , pp. e1045
    • Barbu, C.1
  • 91
    • 40849085098 scopus 로고    scopus 로고
    • Modelling geographic variation in the cost-effectiveness of control policies for infectious vector diseases: the example of Chagas disease
    • Castillo-Riquelme M., et al. Modelling geographic variation in the cost-effectiveness of control policies for infectious vector diseases: the example of Chagas disease. J. Health Econ. 2008, 27:405-426.
    • (2008) J. Health Econ. , vol.27 , pp. 405-426
    • Castillo-Riquelme, M.1
  • 92
    • 0031919729 scopus 로고    scopus 로고
    • A cost-benefit analysis of Chagas disease control in north-western Argentina
    • Basombrio M.A., et al. A cost-benefit analysis of Chagas disease control in north-western Argentina. Trans. R. Soc. Trop. Med. Hyg. 1998, 92:137-143.
    • (1998) Trans. R. Soc. Trop. Med. Hyg. , vol.92 , pp. 137-143
    • Basombrio, M.A.1
  • 93
    • 78149258813 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent
    • Meheus F., et al. Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl. Trop. Dis. 2010, 4:e818.
    • (2010) PLoS Negl. Trop. Dis. , vol.4 , pp. e818
    • Meheus, F.1
  • 94
    • 33846992325 scopus 로고    scopus 로고
    • Drug policy for visceral leishmaniasis: a cost-effectiveness analysis
    • Vanlerberghe V., et al. Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Trop. Med. Int. Health 2007, 12:274-283.
    • (2007) Trop. Med. Int. Health , vol.12 , pp. 274-283
    • Vanlerberghe, V.1
  • 95
    • 0036434128 scopus 로고    scopus 로고
    • How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis
    • Boelaert M., et al. How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis. Trop. Med. Int. Health 2002, 7:955-959.
    • (2002) Trop. Med. Int. Health , vol.7 , pp. 955-959
    • Boelaert, M.1
  • 96
    • 0032877598 scopus 로고    scopus 로고
    • Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis
    • Boelaert M., et al. Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis. Bull. World Health Organ. 1999, 77:667-674.
    • (1999) Bull. World Health Organ. , vol.77 , pp. 667-674
    • Boelaert, M.1
  • 97
    • 84859565853 scopus 로고    scopus 로고
    • The economic value of a visceral leishmaniasis vaccine in Bihar state, India
    • Lee B.Y., et al. The economic value of a visceral leishmaniasis vaccine in Bihar state, India. Am. J. Trop. Med. Hyg. 2012, 86:417-425.
    • (2012) Am. J. Trop. Med. Hyg. , vol.86 , pp. 417-425
    • Lee, B.Y.1
  • 98
    • 0001037329 scopus 로고
    • Togetherness among schistosomes: its effects on the dynamics of the infection
    • May R.M. Togetherness among schistosomes: its effects on the dynamics of the infection. Math. Biosci. 1977, 35:301-343.
    • (1977) Math. Biosci. , vol.35 , pp. 301-343
    • May, R.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.